BzODZ-EPyr

BzODZ-EPyr is an indole based synthetic cannabinoid that has been sold as a designer drug in Russia.[1]

BzODZ-EPyr
Legal status
Legal status
Identifiers
IUPAC name
  • 3-(3-Benzyl-1,2,4-oxadiazol-5-yl)-1-[2-(pyrrolidin-1-yl)ethyl]-1H-indole
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC23H24N4O
Molar mass372.472 g·mol−1
3D model (JSmol)
SMILES
  • C(C1=CC=CC=C1)C2=NOC(=N2)C3=C[N](C4=CC=CC=C34)CCN5CCCC5
InChI
  • InChI=1S/C23H24N4O/c1-2-8-18(9-3-1)16-22-24-23(28-25-22)20-17-27(15-14-26-12-6-7-13-26)21-11-5-4-10-19(20)21/h1-5,8-11,17H,6-7,12-16H2
  • Key:RUVOQWMACBDQDK-UHFFFAOYSA-N

It acts as a CB1 receptor agonist with a pKB value of 7.2 and demonstrates that replacing the ketone in 3-carbonylindoles with an oxadiazole spacer does generally not lead to activity loss.[2][3]

See also

References
  1. Shevyrin V, Melkozerov V, Eltsov O, Shafran Y, Morzherin Y (February 2016). "Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances". Forensic Science International. 259: 95–100. doi:10.1016/j.forsciint.2015.12.019. PMID 26771874.
  2. Moloney GP, Angus JA, Robertson AD, Stoermer MJ, Robinson M, Wright CE, et al. (March 2008). "Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor". European Journal of Medicinal Chemistry. 43 (3): 513–39. doi:10.1016/j.ejmech.2007.04.007. PMID 17582659.
  3. US 6930118, Moloney PG, Robertson AD, "3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives", issued 2005, assigned to Amrad Operations Pty. Ltd.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.